Exact Mass: 552.3635

Exact Mass Matches: 552.3635

Found 61 metabolites which its exact mass value is equals to given mass value 552.3635, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Elastin

(2S)-1-[(2S)-2-[[2-[[(2S,3S)-2-[[(2S)-2-acetamido-4-methylpentanoyl]amino]-3-methylpentanoyl]amino]acetyl]amino]-3-methylbutanoyl]-N-methylpyrrolidine-2-carboxamide

C27H48N6O6 (552.3635)


   

Cyclopassifloic acid E

4,6,14-trihydroxy-7,12,16-trimethyl-15-[2,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O8 (552.3662)


Cyclopassifloic acid E is found in fruits. Cyclopassifloic acid E is a constituent of Passiflora edulis (passion fruit) Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid E is found in fruits.

   

Nonadecylresorcinol glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(3-hydroxy-5-nonadecylphenoxy)oxane-2-carboxylic acid

C31H52O8 (552.3662)


Nonadecylresorcinol glucuronide is an alkylresorcinol metabolite. It is a potential plasma biomarker of whole grain intake (PMID: 25527657).

   

Elastin

1-{2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-4-methylpentylidene}amino)-3-methylpentylidene]amino}ethylidene)amino]-3-methylbutanoyl}-N-methylpyrrolidine-2-carboximidate

C27H48N6O6 (552.3635)


   

Gilteritinib

6-Ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-2-pyrazinecarboxamide

C29H44N8O3 (552.3536)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

DG(8:0/PGE2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3662)


DG(8:0/PGE2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGE2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/8:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl octanoic acid

C31H52O8 (552.3662)


DG(PGE2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGE2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/PGE2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3662)


DG(8:0/0:0/PGE2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGE2/0:0/8:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3662)


DG(PGE2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/PGD2/0:0)

(2S)-3-Hydroxy-2-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3662)


DG(8:0/PGD2/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/PGD2/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/8:0/0:0)

(2S)-1-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propan-2-yl octanoic acid

C31H52O8 (552.3662)


DG(PGD2/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(PGD2/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/PGD2)

(2R)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3662)


DG(8:0/0:0/PGD2) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(PGD2/0:0/8:0)

(2S)-2-Hydroxy-3-{[(5Z)-7-[(1R,2R,5S)-5-hydroxy-2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-3-oxocyclopentyl]hept-5-enoyl]oxy}propyl octanoic acid

C31H52O8 (552.3662)


DG(PGD2/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

(2S)-1-hydroxy-3-(octanoyloxy)propan-2-yl (5S,6S,7E,9E,11Z,13E,15S)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C31H52O8 (552.3662)


DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0)

(2S)-3-Hydroxy-2-(octanoyloxy)propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C31H52O8 (552.3662)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

(2R)-2-Hydroxy-3-(octanoyloxy)propyl (5R,6R,7E,9E,11Z,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoic acid

C31H52O8 (552.3662)


DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl (5R,6R,7E,9E,11Z,13E,15R)-5,6,15-trihydroxyicosa-7,9,11,13-tetraenoate

C31H52O8 (552.3662)


DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-fucopyranoside

3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labd-7-ene-2-O-beta-fucopyranoside

C31H52O8 (552.3662)


   

20S,23R,24R-23-chloro-20,24-epoxy-dammarane-3alpha,24,25-triol 3-acetate

20S,23R,24R-23-chloro-20,24-epoxy-dammarane-3alpha,24,25-triol 3-acetate

C32H53ClO5 (552.3581)


   

halolitoralin A

halolitoralin A

C27H48N6O6 (552.3635)


   

Drevogenin I

Drevogenin I

C31H52O8 (552.3662)


   

Cyclopassifloic acid E

4,6,14-trihydroxy-7,12,16-trimethyl-15-[2,5,6-trihydroxy-5-(propan-2-yl)hexan-2-yl]pentacyclo[9.7.0.0^{1,3}.0^{3,8}.0^{12,16}]octadecane-7-carboxylic acid

C31H52O8 (552.3662)


   

Z-D-Tyt(tBu)-OH.DCHA

Z-D-Tyt(tBu)-OH.DCHA

C33H48N2O5 (552.3563)


   

Z-Tyr(tBu)-OH.DCHA

Z-Tyr(tBu)-OH.DCHA

C33H48N2O5 (552.3563)


   

Gilteritinib

Gilteritinib

C29H44N8O3 (552.3536)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor

   

Nonadecylresorcinol glucuronide

Nonadecylresorcinol glucuronide

C31H52O8 (552.3662)


   

DG(8:0/PGE2/0:0)

DG(8:0/PGE2/0:0)

C31H52O8 (552.3662)


   

DG(PGE2/8:0/0:0)

DG(PGE2/8:0/0:0)

C31H52O8 (552.3662)


   

DG(8:0/0:0/PGE2)

DG(8:0/0:0/PGE2)

C31H52O8 (552.3662)


   

DG(PGE2/0:0/8:0)

DG(PGE2/0:0/8:0)

C31H52O8 (552.3662)


   

DG(8:0/PGD2/0:0)

DG(8:0/PGD2/0:0)

C31H52O8 (552.3662)


   

DG(PGD2/8:0/0:0)

DG(PGD2/8:0/0:0)

C31H52O8 (552.3662)


   

DG(8:0/0:0/PGD2)

DG(8:0/0:0/PGD2)

C31H52O8 (552.3662)


   

DG(PGD2/0:0/8:0)

DG(PGD2/0:0/8:0)

C31H52O8 (552.3662)


   

DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

DG(8:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0)

C31H52O8 (552.3662)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/8:0/0:0)

C31H52O8 (552.3662)


   

DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

DG(8:0/0:0/20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S))

C31H52O8 (552.3662)


   

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0)

DG(20:4(7E,9E,11Z,13E)-3OH(5S,6R,15S)/0:0/8:0)

C31H52O8 (552.3662)


   

[O-(1-O-Hexadecanoyl-2-O-propanoyl-L-glycero-3-phospho)choline]anion

[O-(1-O-Hexadecanoyl-2-O-propanoyl-L-glycero-3-phospho)choline]anion

C27H55NO8P+ (552.3665)


   

2-[(2-Decanoyloxy-3-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Decanoyloxy-3-nonanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[(2-Hexadecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Hexadecanoyloxy-3-propanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[Hydroxy-(3-octanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(3-octanoyloxy-2-undecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[(3-Acetyloxy-2-heptadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Acetyloxy-2-heptadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[Hydroxy-(3-pentanoyloxy-2-tetradecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(3-pentanoyloxy-2-tetradecanoyloxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[(2-Dodecanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(2-Dodecanoyloxy-3-heptanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[(3-Hexanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Hexanoyloxy-2-tridecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

2-[(3-Butanoyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[(3-Butanoyloxy-2-pentadecanoyloxypropoxy)-hydroxyphosphoryl]oxyethyl-trimethylazanium

C27H55NO8P+ (552.3665)


   

ST 25:0;O2;GlcA

ST 25:0;O2;GlcA

C31H52O8 (552.3662)


   

ST 25:1;O3;Hex

ST 25:1;O3;Hex

C31H52O8 (552.3662)


   

3,9,15-trimethyl-6,12-bis(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

3,9,15-trimethyl-6,12-bis(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

C27H48N6O6 (552.3635)


   

(1s,3s,4s,6s,7s,8r,11s,12s,14s,15r,16r)-4,6,14-trihydroxy-7,12,16-trimethyl-15-[(2s,5s)-2,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

(1s,3s,4s,6s,7s,8r,11s,12s,14s,15r,16r)-4,6,14-trihydroxy-7,12,16-trimethyl-15-[(2s,5s)-2,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid

C31H52O8 (552.3662)


   

(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,4r,5s)-4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,4r,5s)-4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H53ClO5 (552.3581)


   

(3s,6s,9s,12s,15s,18s)-3-[(2s)-butan-2-yl]-6,12,18-trimethyl-9,15-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

(3s,6s,9s,12s,15s,18s)-3-[(2s)-butan-2-yl]-6,12,18-trimethyl-9,15-bis(2-methylpropyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

C27H48N6O6 (552.3635)


   

3-[5,7-dihydroxy-4a,8-dimethyl-2-(5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

3-[5,7-dihydroxy-4a,8-dimethyl-2-(5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

C31H52O8 (552.3662)


   

5-(5-hydroxy-3-methylpentyl)-1,1,4a,6-tetramethyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

5-(5-hydroxy-3-methylpentyl)-1,1,4a,6-tetramethyl-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]-2,3,4,5,8,8a-hexahydronaphthalen-2-yl 2-methylbut-2-enoate

C31H52O8 (552.3662)


   

(2s,3s,4as,5r,8as)-5-[(3s)-5-hydroxy-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

(2s,3s,4as,5r,8as)-5-[(3s)-5-hydroxy-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C31H52O8 (552.3662)


   

(2e)-3-[(1s,2r,4as,5r,7r,8r,8as)-5,7-dihydroxy-4a,8-dimethyl-2-[(2e,5s,7r,9r,10s,11s)-5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

(2e)-3-[(1s,2r,4as,5r,7r,8r,8as)-5,7-dihydroxy-4a,8-dimethyl-2-[(2e,5s,7r,9r,10s,11s)-5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid

C31H52O8 (552.3662)


   

(3s,6s,9s,12s,15s,18s)-3,9,15-trimethyl-6,12-bis(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

(3s,6s,9s,12s,15s,18s)-3,9,15-trimethyl-6,12-bis(2-methylpropyl)-18-(sec-butyl)-1,4,7,10,13,16-hexaazacyclooctadeca-1,4,7,10,13,16-hexaene-2,5,8,11,14,17-hexol

C27H48N6O6 (552.3635)


   

(2s,3s,4as,5r,8as)-5-[(3s)-5-hydroxy-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

(2s,3s,4as,5r,8as)-5-[(3s)-5-hydroxy-3-methylpentyl]-1,1,4a,6-tetramethyl-3-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate

C31H52O8 (552.3662)


   

(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,4r,5r)-4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

(1s,3ar,3br,5ar,7r,9ar,9br,11ar)-1-[(2s,4r,5r)-4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H53ClO5 (552.3581)


   

1-[4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

1-[4-chloro-5-hydroxy-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3a,3b,6,6,9a-pentamethyl-dodecahydro-1h-cyclopenta[a]phenanthren-7-yl acetate

C32H53ClO5 (552.3581)